Aurobindo Pharma Ltd

BSE Code : 524804
NSE Symbol : AUROPHARMA
ISIN : INE406A01037
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

1,051.50 -20.80(-1.94%)

Open Price (₹)

1,060.10

Prev. Close (₹)

1,072.30

Volume (No’s)

626,241

Market Cap (₹)

62,830.20

Low Price (₹)

1,049.30

High Price (₹)

1,084.30

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
31-Mar-2026	NA	The Board of Directors of the company at its meeting held today August 4, 2025, has approved the payment of Interim Dividend of 400% i.e Rs.4.00 (Rupees Four Only) per equity share of Rs.1. /- each on equity share capital of the company, The Company has fixed August 8, 2025 as the record date for purpose of the payment of interim Dividend and the same will paid on or before August 21, 2025.
08-Aug-2025	NA	The Board of Directors of the company at its meeting held today August 4, 2025, has approved the payment of Interim Dividend of 400% i.e Rs.4.00 (Rupees Four Only) per equity share of Rs.1. /- each on equity share capital of the company, The Company has fixed August 8, 2025 as the record date for purpose of the payment of interim Dividend and the same will paid on or before August 21, 2025.
08-Aug-2025	NA	400% Interim Dividend
04-Aug-2025	NA	Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve Intimation of Board Meeting for consideration of unaudited Financial Results for the quarter ended June 30 2025 and Dividend. The Board of Directors of the Company at its meeting held today, August 4, 2025, has, inter alia, considered and approved: - 1. the standalone and consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Reports issued by the Statutory Auditors. 2. the payment of interim dividend of 400% i.e. Rs.4.00 (Rupee Four only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has fixed August 8, 2025, as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before August 21, 2025. (As Per BSE Announcement Dated on:04.08.2025)
26-May-2025	NA	Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Intimation of Board meeting to be held on May 26 2025 to consider Audited Financial Results for the fourth quarter and financial year ended March 31 2025. Intimation of appointment of Secretarial Auditors (As Per BSE Announcement dated on 26.05.2025)